Search - tctmd.com

Displaying 1 - 20 of 74

Sort: Relevancy | Date

News Conference News ISC 2026

OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding

Todd Neale

February 09, 2026

News Daily News

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

L.A. McKeown

February 04, 2026

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

L.A. McKeown

November 24, 2025

News Daily News

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

Yael L. Maxwell

November 10, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2025

Shelley Wood

January 31, 2025

News Daily News

Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients

L.A. McKeown

January 06, 2025

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Todd Neale

December 19, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

L.A. McKeown

October 25, 2024

News Daily News

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Michael O'Riordan

August 19, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Daily News

Kidney Events High in Older Patients After HF Hospitalization

L.A. McKeown

May 30, 2024

News Daily News

Patients With CKD Remain Underrepresented in Trials of CV Meds

Todd Neale

March 08, 2024

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

L.A. McKeown

January 19, 2024

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

Advertisement

OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

November 2025 Dispatch for the CV Team

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

TCTMD’s Top 10 Most Popular Stories for January 2025

Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

October 2024 Dispatch for the CV Team

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

July 2024 Dispatch for the CV Team

Kidney Events High in Older Patients After HF Hospitalization

Patients With CKD Remain Underrepresented in Trials of CV Meds

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

Vast Majority of HFrEF Patients Eligible for Vericiguat

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content